BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15725093)

  • 1. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification.
    Brouwer JL; Veeger NJ; van der Schaaf W; Kluin-Nelemans HC; van der Meer J
    Br J Haematol; 2005 Mar; 128(5):703-10. PubMed ID: 15725093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; van der Meer J
    Br J Haematol; 2007 Jul; 138(1):110-6. PubMed ID: 17555454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
    Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
    Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations.
    Ten Kate MK; Platteel M; Mulder R; Terpstra P; Nicolaes GA; Reitsma PH; van der Steege G; van der Meer J
    Hum Mutat; 2008 Jul; 29(7):939-47. PubMed ID: 18435454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III families.
    Castoldi E; Maurissen LF; Tormene D; Spiezia L; Gavasso S; Radu C; Hackeng TM; Rosing J; Simioni P
    Haematologica; 2010 Apr; ():. PubMed ID: 20378562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.
    Libourel EJ; Bank I; Veeger NJ; Hamulyàk K; Middeldorp S; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2005 Mar; 16(2):135-40. PubMed ID: 15741801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study.
    Pabinger I; Kyrle PA; Heistinger M; Eichinger S; Wittmann E; Lechner K
    Thromb Haemost; 1994 Apr; 71(4):441-5. PubMed ID: 8052960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
    van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
    Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
    Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
    Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
    Bank I; van de Poel MH; Coppens M; Hamulyák K; Prins MH; van der Meer J; Veeger NJ; Büller HR; Middeldorp S
    Thromb Haemost; 2007 Nov; 98(5):1040-4. PubMed ID: 18000609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
    Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal state rather than age influences cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency.
    Liberti G; Bertina RM; Rosendaal FR
    Thromb Haemost; 1999 Sep; 82(3):1093-6. PubMed ID: 10494769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel PROS1 c.1113T-->GG frameshift mutation in a family with mixed type I/type III protein S deficiency.
    ten Kate MK; Mulder R; Platteel M; Brouwer JL; van der Steege G; van der Meer J
    Haematologica; 2006 Aug; 91(8):1151-2. PubMed ID: 16885060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
    Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free protein S deficiency is a risk factor for venous thrombosis.
    Faioni EM; Valsecchi C; Palla A; Taioli E; Razzari C; Mannucci PM
    Thromb Haemost; 1997 Nov; 78(5):1343-6. PubMed ID: 9408016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary protein S deficiency in young adults with arterial occlusive disease.
    Allaart CF; Aronson DC; Ruys T; Rosendaal FR; van Bockel JH; Bertina RM; Briët E
    Thromb Haemost; 1990 Oct; 64(2):206-10. PubMed ID: 2148653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.